BioSpace News Archive

Deals

Psychemedics Corporation Announces 4th Quarter and Year-End ResultsDeclares 94th Consecutive Quarterly Dividend

Psychemedics Corporation announced fourth quarter and year-end financial results for the period ended December 31, 2019.

February 11, 2020

·

10 min read

Policy

Astex Pharmaceuticals Announces U.S. Food and Drug Administration (FDA) Acceptance for Review of an NDA for the Combination Oral Hypomethylating Agent Cedazuridine and Decitabine (ASTX727 or oral C-DEC), for the Treatment of MDS and CMML

Astex Pharmaceuticals, Inc., a wholly owned subsidiary of Otsuka Pharmaceutical Co. Ltd., based in Japan, announced that the U.S. FDA has accepted for Priority Review its NDA for oral C-DEC as a treatment for adults with previously untreated intermediate- and high-risk MDS including CMML.

February 11, 2020

·

8 min read

Business

U.S. Army Veteran Receives Award for Excellence in Prosthodontics

Dr. John R. Agar honored with Federal Services Award by the American College of Prosthodontists.

February 11, 2020

·

1 min read

Deals

Fortress Biotech Announces Pricing of Series A Preferred Stock Offering - Feb. 11, 2020

Fortress Biotech, Inc. announced that it has priced an underwritten public offering of 625,000 shares of its 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock at a price of $20 per share, with expected gross proceeds to Fortress of $12.5 million.

February 11, 2020

·

5 min read

Deals

Theravance Biopharma Announces Pricing of Public Offering of Ordinary Shares

Theravance Biopharma, Inc., a diversified biopharmaceutical company primarily focused on the discovery, development and commercialization of organ-selective medicines, announced the pricing of its underwritten public offering of 5,500,000 ordinary shares at a price to the public of $27.00 per share.

February 11, 2020

·

3 min read

Job Trends

Clovis Oncology to Present at the 9th Annual SVB Leerink Healthcare Conference

Clovis Oncology, Inc. announced that its Chief Executive Officer and President, Patrick J. Mahaffy, will present at the 9th Annual SVB Leerink Global Healthcare Conference on Wednesday, February 26, 2020 at 10:30 a.m. Eastern Standard Time.

February 11, 2020

·

1 min read

Deals

PolarityTE Announces Public Offering of Common Stock and Warrants

PolarityTE, Inc., a biotechnology company developing and commercializing regenerative tissue products and biomaterials, announced that it has commenced an underwritten public offering of shares of its common stock and warrants to purchase shares of its common stock.

February 11, 2020

·

3 min read

Drug Development

Adamas Announces Publication of the Two-Year Phase 3 Open-Label EASE LID 2 Trial of GOCOVRI® for Dyskinesia in Patients with Parkinson’s Disease

Final results reported from the longest-running clinical trial of an amantadine product in Parkinson’s disease

February 11, 2020

·

7 min read

Biotech Beach

AVITA Medical to Present at the Cowen 40th Annual Health Care Conference

AVITA Medical, a global regenerative medicine company, announced that management will present at the Cowen 40th Annual Health Care Conference in Boston.

February 11, 2020

·

4 min read

Business

Vigil Reports Third Quarter 2019 Results

Vigil Health Solutions Inc. announces the results of operations for the quarter ending December 31, 2019.

February 11, 2020

·

8 min read